FS
Fresenius SE & Co. KGaA
FSNUF · OTC
$54.35 +0.00% (+$0.00)
Market Cap 26.7B €
P/E Ratio 17.51x
Div. Yield 2.25%
ROE 7.89%
Bulios Fair Price
$34.52
36.5% downside
Current Price
$54.35
Undervalued Fair Value Overvalued
According to Bulios Fair Price, FSNUF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
80 /100
Cheap EV/EBITDA 10.82x
P/S 1.14x
P/B 1.36x
Growth
1 /100
Declining Rev. growth 17.58%
FCF growth 19.33%
Book val. growth 2.20%
Profitability
44 /100
Moderate Net margin 6.50%
Op. margin 9.60%
FCF margin 6.18%
Quality
33 /100
Poor ROE 7.89%
ROA 3.65%
Asset turnover 0.56x
Debt
61 /100
Moderate Current ratio 1.28x
Int. coverage 7.49x
Net debt/EBITDA 2.98x
Stability
42 /100
Moderate Rev. volatility 27.19%
EPS volatility 174.34%
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about FSNUF
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Michael Sen
Employees
178,394
Headquarters
Bad Homburg vor der Höhe
Upcoming events
04 NOV
Earnings
Upcoming earnings report